These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Westerhout EM; Ooms M; Vink M; Das AT; Berkhout B Nucleic Acids Res; 2005; 33(2):796-804. PubMed ID: 15687388 [TBL] [Abstract][Full Text] [Related]
4. A novel program to design siRNAs simultaneously effective to highly variable virus genomes. Lee HS; Ahn J; Jun EJ; Yang S; Joo CH; Kim YK; Lee H Biochem Biophys Res Commun; 2009 Jul; 384(4):431-5. PubMed ID: 19422797 [TBL] [Abstract][Full Text] [Related]
5. A protocol for designing siRNAs with high functionality and specificity. Birmingham A; Anderson E; Sullivan K; Reynolds A; Boese Q; Leake D; Karpilow J; Khvorova A Nat Protoc; 2007; 2(9):2068-78. PubMed ID: 17853862 [TBL] [Abstract][Full Text] [Related]
9. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors. Sun Y; Li Z; Li L; Li J; Liu X; Li W Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648 [TBL] [Abstract][Full Text] [Related]
10. Optimal design and validation of antiviral siRNA for targeting hepatitis B virus. Fu J; Tang ZM; Gao X; Zhao F; Zhong H; Wen MR; Sun X; Song HF; Qian XH Acta Pharmacol Sin; 2008 Dec; 29(12):1522-8. PubMed ID: 19026173 [TBL] [Abstract][Full Text] [Related]
11. Positional effects and strand preference of RNA interference against hepatitis C virus target sequences. Smith RM; Smolic R; Volarevic M; Wu GY J Viral Hepat; 2007 Mar; 14(3):194-212. PubMed ID: 17305886 [TBL] [Abstract][Full Text] [Related]
12. Effective siRNA targeting of the 3' untranslated region of the West Nile virus genome. Anthony KG; Bai F; Krishnan MN; Fikrig E; Koski RA Antiviral Res; 2009 Jun; 82(3):166-8. PubMed ID: 19135091 [TBL] [Abstract][Full Text] [Related]
13. Suppression of bovine viral diarrhea virus replication by small interfering RNA and short hairpin RNA-mediated RNA interference. Lambeth LS; Moore RJ; Muralitharan MS; Doran TJ Vet Microbiol; 2007 Jan; 119(2-4):132-43. PubMed ID: 17052865 [TBL] [Abstract][Full Text] [Related]
14. Broad-spectrum antiviral activity of small interfering RNA targeting the conserved RNA termini of Lassa virus. Müller S; Günther S Antimicrob Agents Chemother; 2007 Jun; 51(6):2215-8. PubMed ID: 17371814 [TBL] [Abstract][Full Text] [Related]
15. RFRCDB-siRNA: improved design of siRNAs by random forest regression model coupled with database searching. Jiang P; Wu H; Da Y; Sang F; Wei J; Sun X; Lu Z Comput Methods Programs Biomed; 2007 Sep; 87(3):230-8. PubMed ID: 17644215 [TBL] [Abstract][Full Text] [Related]
16. The efficacy of siRNAs against hepatitis C virus is strongly influenced by structure and target site accessibility. Sagan SM; Nasheri N; Luebbert C; Pezacki JP Chem Biol; 2010 May; 17(5):515-27. PubMed ID: 20534349 [TBL] [Abstract][Full Text] [Related]
17. Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs. von Eije KJ; ter Brake O; Berkhout B J Gene Med; 2009 Jun; 11(6):459-67. PubMed ID: 19384894 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of picornaviruses by means of RNA interference. Rothe D; Werk D; Dutkiewicz M; Schubert S; Grunert HP; Zeichhardt H; Erdmann VA; Fechner H; Kurreck J Nucleic Acids Symp Ser (Oxf); 2008; (52):63-4. PubMed ID: 18776254 [TBL] [Abstract][Full Text] [Related]
19. RNA interference as a tool for exploring HIV-1 robustness. Nevot M; Martrus G; Clotet B; Martínez MA J Mol Biol; 2011 Oct; 413(1):84-96. PubMed ID: 21875599 [TBL] [Abstract][Full Text] [Related]